Title:
肺疾患治療剤
Document Type and Number:
Japanese Patent JP5808470
Kind Code:
B2
Abstract:
The present invention provides an agent for inhibiting alveolar airspace enlargement containing adiponectin or an agent for inhibiting alveolar wall destruction containing adiponectin. The pulmonary disease therapeutic agents of the present invention are highly safe drugs that possess an excellent effect of decreasing the deterioration of the pulmonary function, such as airflow limitation, and exhibit an extremely high effect of treating pulmonary disease accompanied by irreversible deterioration in pulmonary function, with fewer adverse side effects such as nausea, vomiting and gastric acid secretion.
More Like This:
| WO/2000/059881 | SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS |
| WO/2005/102376 | PREVENTIVE/REMEDY FOR DIABETIC NEPHROPATHY |
| WO/2001/089319 | TRYPTOPHAN SOURCE FROM PLANTS AND USES THEREFOR |
Inventors:
Takanori
Kazama Kirima
Keiko Karasani
Anichi Omoto
Youichi Yabuuchi
Kazama Kirima
Keiko Karasani
Anichi Omoto
Youichi Yabuuchi
Application Number:
JP2014185913A
Publication Date:
November 10, 2015
Filing Date:
September 12, 2014
Export Citation:
Assignee:
Otsuka Pharmaceutical Co., Ltd.
International Classes:
A61K38/00; A61P11/00
Domestic Patent References:
| JP2005535561A | ||||
| JP2008523057A |
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office